COMPANY PROFILE / #1360
Empress (Drug Discovery)
Watertown, MAVenture Capital-Backed
OVERVIEW
Operator of an early-stage biotechnology company intended for drug development and new molecular insights into health and disease. The company's proprietary bio platform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to discover advanced starting points in endogenous drug-like molecules, enabling clinicians to treat a wide range of serious unmet medical needs with small-molecule drug candidates.
已融资80.19
最新估值185.00
员工数22
成立年份2020
公司概况
- Companies
- Empress (Drug Discovery)
- Description
- Operator of an early-stage biotechnology company intended for drug development and new molecular insights into health and disease. The company's proprietary bio platform harnesses the power of evolution, human molecular and genetic data, and artificial intelligence to discover advanced starting points in endogenous drug-like molecules, enabling clinicians to treat a wide range of serious unmet medical needs with small-molecule drug candidates.
- Website
- www.empresstx.com
- HQ Location
- Watertown, MA
- Year Founded
- 2020
- Keywords
- biotech company, drug development, drug discovery, healthcare research, machine learning technology, medicine tools
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 80.19
- First Financing Date
- 06-Dec-2021
- First Financing Size
- 30.19
- First Financing Valuation
- 64.19
- Last Financing Date
- 01-Oct-2023
- Last Financing Deal Type
- Early Stage VC
- Last Financing Size
- 50.00
- Last Financing Valuation
- 185.00
- Last Financing Status
- Completed
- Last Known Valuation
- 185.00
- Last Known Valuation Date
- 01-Oct-2023
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- 264.18
- Valuation Estimate Growth Rate
- 42.80%
- Active Investors
- Flagship Pioneering, Forward Asset Management, J2 Ventures
- # Active Investors
- 3
- Acquirers
- —
团队与联系人
- Employees
- 22
- Employee Growth %
- -15.38% E
- Employee History
- 2025: 22, 2024: 26 E, 2023: 30, 2022: 27
- Primary Contact
- Boris Hayete
- Primary Contact Title
- Senior Vice President of Computational Biology
- Primary Contact Email
- bhayete@empresstx.com
- Primary Contact Phone
- +1 (617) 374-2336
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.00%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 1.50x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 64
- Majestic Referring Domains
- 39
- SimilarWeb Unique Visitors
- 0
- SimilarWeb Unique Visitors Change
- -20
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 11%
- Success Probability Over Time – 3 Year
- 27%
- Success Probability Over Time – 5 Year
- 39%
记录来源：public.companies · 原始序号 #1360 · 所有字段均按数据库原值展示。